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Seeking smaller and indistinct incisions, physicians have attempted endoscopic breast surgery in breast 
cancer patients. Unfortunately, there are some limitations in the range of movement and visualization 
of the operation field. Potentially addressing these limitations, we investigated the outcomes of gas 
and gasless robot-assisted nipple-sparing mastectomy (RAnSM) with immediate breast reconstruction 
(IBR). Ten patients underwent 12 RANSM with IBR between November 2016 and April 2018. Patients 
with tumors measuring >5 cm in diameter, tumor invasion of the skin or nipple-areolar complex, 
proven metastatic lymph nodes, or planned radiotherapy were excluded. Age, breast weight, diagnosis, 
tumor size, hormone receptor status, and operation time were retrospectively collected. postoperative 
outcomes including postoperative complications and final margin status of resected were analyzed. The 
median total operation time and console time were 351 min (267–480 min) and 51 min (18–143 min), 
respectively. the learning curve presented as a cumulative sum graph showed that the console time 
decreased and then stabilized at the eighth case. there was no open conversion or major postoperative 
complication. one patient had self-resolved partial nipple ischemia, and two patients experienced 
partial skin ischemia. We deemed that RAnSM with iBR is safe and feasible for early breast cancer, 
benign disease of the breast, and BRCA 1/2 mutation carriers. RAnSM is an advanced surgical method 
with a short learning curve.
Nipple-sparing mastectomy (NSM) is popular secondary to the excellent cosmetic effects achieved in appropri-
ately selected patients1. However, a conspicuous scar on the breast dome and a change in the shape of the breast 
are unavoidable. An inframammary fold or lateral or periareolar incision ensures an inconspicuous scar; however, 
removal of adequate quantities of breast tissue is technically challenging2. The risk of nipple necrosis associated 
with a periareolar incision is higher than that with a non-periareolar incision3. Aesthetically, endoscopic breast 
surgery is expected to achieve complete cancer clearance with preservation of the patient’s body image4. However, 
restricted maneuverability (because of inflexible endoscopic equipment) and inadequate operative field visuali-
zation (because of 2-dimensional cameras) are limitations of this technique4,5.
Robotic surgery is widely used across various fields since its introduction in 19856 because of its several 
incomparable advantages. High-resolution, 10-fold image magnification, and 3-dimensional optics enable accu-
rate visualization and differentiation of fine structures including intercostal perforators and lymphatics7. The 
sophisticated and intuitive motion of robotic arms allows microscale manipulation, and surgeons can perform 
delicate tasks accurately even in a limited operative field. Thus, robotic surgery scores over endoscopic surgery 
and is widely used for several intracorporeal procedures. Toesca et al. first introduced robotic breast surgery in 
2015 after which this technique was attempted globally5,8. Only a few studies have evaluated the feasibility and 
safety of robot-assisted nipple-sparing mastectomy (RANSM) with immediate breast reconstruction (IBR) to 
treat breast cancer. Not many studies have analyzed the learning curve of RANSM. We investigated the outcome 
of RANSM with IBR and analyzed the learning curve for this procedure.
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patients and Methods
cadaveric study. Prior to evaluating the feasibility and safety of RANSM with IBR in humans, RANSM 
with a latissimus dorsi flap and/or implant insertion was performed on cadavers between December 2013 and 
November 2014 (Fig. 1). The sources of cadavers were body donation programs or unclaimed bodies provided by 
the Severance robot and MIS center9,10. Six breasts in 3 cadavers were used for the initial RANSM with IBR, and 
feasibility and safety of the procedure were evaluated. The cadaveric study was performed by 2 breast surgeons 
and 2 plastic surgeons. A Chung’s or modified Chung’s retractor for endoscopic and robotic surgeries was utilized 
during the gasless technique. The detailed procedure of a gasless RANSM has been described in a previous case 
report11. During the first attempted cadaveric RANSM, the breast surgeons could not identify the anatomical 
borders of the breast. Thus, indigo carmine was injected into the borders of the breast parenchyma to identify the 
anatomical borders of the breast. After injection of the dye, the anatomical borders of the breast could be identi-
fied within the working space without help from assistants during the second and third cadaveric studies. Barring 
this aforementioned technical issue, no significant failure or safety issue occurred during cadaveric RANSM with 
IBR. In addition to the cadaveric study, the surgeons also participated in the essential robot-training programs 
conducted by the Severance Robot & Minimally Invasive Surgery center to gain experience in basic and advanced 
robotic surgical skills.
patient selection. Between November 2016 and April 2018, 10 patients underwent RANSM with IBR at a 
single center. This study was approved by the Institutional Review Board of Severance Hospital including waiver 
of consent for the current study because the study involved only a retrospective chart review of anonymous 
patients.
A single breast surgeon and 2 plastic surgeons performed 12 RANSM with IBR (2 patients underwent bilat-
eral procedures). Selected patients underwent physical examination, mammogram, breast ultrasonography and 
magnetic resonance imaging. Chest or abdominopelvic computed tomography, abdominal ultrasonography, or 
whole body bone scan were performed to assess metastasis. Patients with tumors measuring >5 cm in diameter, 
those with skin or nipple-areolar complex (NAC) tumor invasion, those showing metastatic lymph nodes, or 
those scheduled for radiotherapy were excluded. We recorded age, body mass index, breast weight, diagnosis, 
tumor size and grade, number of metastatic lymph nodes, hormone receptor status, and type of adjuvant therapy. 
Postoperative complications and final margin status of resected specimens were evaluated to investigate postop-
erative outcomes. The operation time was measured as the interval between the creation of the skin incision and 
the end of the reconstructive surgery. The console time was defined as the time spent by a surgeon to operate the 
console for mastectomy.
Surgical technique. The procedure was performed in the first 10 patients using a gasless technique with 
self-retractors used for robotic and endoscopic surgery. Briefly, a patient was placed in the supine position using 
a shoulder pad. The ipsilateral arm was straightened with internal rotation and abduction and fixed to the head. 
Indigo carmine was injected around the NAC to detect sentinel lymph nodes preoperatively. A 3.5–6 cm sized 
longitudinal skin incision was made in the anterior axillary line below the axillary fossa. Sentinel lymph node 
biopsy was performed manually without robotic assistance, and the subcutaneous skin flap was dissected toward 
the NAC using monopolar electrocautery. After an adequate working space was obtained, the retroareolar ductal 
tissue was resected for frozen section examination to evaluate tumor involvement. Before docking the da Vinci 
Xi® or Si® Surgical System (Intuitive Surgical Inc., California, US), indigo carmine was injected into the borders 
of the breast to delineate the anatomical boundaries of the breast.
In the gasless method, the retractor was hung to lift the skin flap, and the robot was docked on the contralateral 
side of the patient. Dissection was performed using fenestrated bipolar forceps on the left side and a permanent 
cautery spatula on the right under visual guidance of a dual-channel 30° down endoscope of the robotic system11.
Figure 1. The cadaveric study of robot-assisted nipple-sparing mastectomy with immediate breast 
reconstruction.
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After dissecting the subcutaneous flap, a Chung’s or modified Chung’s retractor was repositioned over the 
pectoralis major fascia and drawn up to expose the posterior aspect of the breast. The breast tissue was detached 
from the fascia and removed through the 3.5–6 cm axillary skin incision.
RANSM with IBR using gas insufflation was performed in the 2 most recent cases as described in a previous 
study7. In brief, carbon dioxide (CO2) gas was insufflated through a single port (Lapsingle®, Sejong Medical 
Inc., Korea). The retroareolar ductal tissue was resected for frozen section examination under robotic vision. 
Dissection of the skin flap was performed using the ProGraspTM forceps (Intuitive Surgical, Sunnyvale, USA) on 
the left side and the Hot ShearsTM monopolar curved scissors (Intuitive Surgical, Sunnyvale, USA) on the right.
Assistants guided the surgeon by providing verbal information/guidance regarding the location of the instru-
ment’s tip and the flap thickness. After the entire breast tissue was removed, the subcutaneous skin flap was 
inspected for bleeding and thickness, and the IBR was performed by the plastic surgeons.
Statistical analysis. This study used 3 case moving average curves (MAC) and cumulative sum (CUSUM) 
analysis to identify the learning curve for RANSM except 2 gas methods of RANSM because different technique 
can affect the result of the learning curve. Previous studies have reported the utility of MAC and CUSUM in ana-
lyzing the learning curves12–14. The slope of the CUSUM graph represents the trend of learning performance, and 
the plateau represents the proficiency acquired.
The SPSS software, version 23 (SPSS Inc., Chicago, IL) was used for statistical analysis. The polynomial curves 
of the MAC and CUSUM diagram were obtained using the Trendline function of Microsoft Excel 2010, and we 
subsequently determined the curve gradients.
Results
clinical and pathological characteristics. The median age of patients was 46 years (29–51 years), and 
the median weight of the resected breast specimens was 225.5 g (150–436 g). Ten mastectomies were performed 
to treat breast cancer—9 cases (75%) presented with invasive ductal carcinoma and 1 case (8.3%) with ductal 
carcinoma in situ (DCIS). The patient with DCIS underwent a bilateral procedure, and a bilateral procedure was 
also performed in a patient with interstitial mastitis secondary to a foreign body injection. The median tumor 
size was 1.35 cm (0.5–4.2 cm). Sentinel lymph node biopsies were performed during all operations except in 1 
patient with interstitial mastitis. Axillary dissection without robotic assistance was performed in a patient show-
ing a positive frozen section biopsy result. One patient with a metastatic lymph node that was not identified by 
the frozen section underwent postoperative radiation therapy. All patients with breast cancer showed estrogen 
receptor positivity and received hormonal therapy. Human epidermal growth factor receptor 2 was overexpressed 
in 3 patients, and 1 of them received targeted therapy. Left breast surgeries were performed in 5 and right breast 
surgeries in 7 cases. Direct-to-implant breast reconstruction was performed in 3 and reconstruction using tissue 
expanders in 9 cases.
Adjuvant chemotherapy was administered in 4 and radiotherapy in 2 patients.
All frozen sections were examined, and histopathological changes were detected in 2 patients. One patient 
with a superficial focal abutting of the skin margin underwent radiotherapy. The other patient showed ductal 
carcinoma of the NAC and underwent excision of the NAC (Tables 1 and 2).
operation time. The median length of hospitalization was 11 days (9–13 days). The median operation time 
was 351 min (267–480 min). The median console time was 51 min (18–143 min) (Table 2). The first 5 patients 
who underwent the operation showed a shorter total operation and console time. However, from the sixth 
case onwards, we observed fluctuations in the operation times. The MAC graph of the 3 cases representing the 
total operation time and the console time also decreased until the fifth case and increased from the sixth case 
onwards. CUSUM analysis showed that the total operation time reduced until the ninth case and increased there-
after (Fig. 2A). The CUSUM graph of the console time decreased until the eighth case and stabilized thereafter 
(Fig. 2B).
postoperative complications. Conversion to open surgery and mortality were not reported. Major 
postoperative complications including hematoma, infection, and total nipple or skin necrosis did not occur. 
Self-limited partial nipple ischemia occurred in 1 and partial skin ischemia in 2 patients (Table 2).
Discussion
This study showed that RANSM with IBR is safe and feasible for patients with early breast cancer. With improved 
disease-free and overall survival rates, patients with early breast cancer are increasingly concerned regarding 
postoperative cosmetic effects and overall quality of life5. Therefore, newer surgical methods that ensure onco-
logic safety without compromising body image are required. We introduced robotic breast surgery to achieve 
these goals. The new surgical method facilitates RANSM with IBR for patients with early breast cancer via a small 
axillary incision. No major postoperative complications including total nipple necrosis, wound infection, and 
implant removal were observed. No negative effects on cosmetic outcomes and quality of life were identified. 
Previous studies have reported similar results of RANSM with IBR5,8,15.
Gasless RANSM with IBR was performed for the first time in our study. The gasless and the CO2-insufflation 
techniques are both associated with specific advantages and disadvantages. The gasless technique utilizes a 
self-retractor (Chung’s retractor) to maintain the working space as an alternative to CO2 gas insufflation16. A dis-
advantage of the CO2-insufflation method is that CO2 gas leakage impairs optimal availability and visualization 
of the working space, and robotic vision can be affected by the smoke released during electrocauterization. The 
gasless technique utilizes retractors to maintain the working space; thus, bleeding or air suction associated with 
this procedure does not significantly impair the availability and visualization of the working space. The smoke 
from electrocauterization causes lesser technical difficulties (lesser visual disturbances) with the gasless technique 
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thereby facilitating a clearer view of the operative field. Postoperative subcutaneous emphysema and hypercapnia 
can complicate the gas insufflation technique5. Although these complications can be managed with supportive 
care15, the gasless robotic procedure eliminates the risks of CO2 insufflation-related complications. Another ben-
efit of the gasless technique is that the retroareolar ductal tissue can be resected to confirm tumor invasion by 
performing frozen section examination prior to docking of the robotic system.
A few disadvantages of the gasless technique must be mentioned. Prolonged retraction can cause skin flap 
ischemia. The length of a single incision required for the gasless technique is longer than that used for the 
gas-insufflated procedure. In this study, we used an axillary incision measuring 2.5–4 cm for the CO2-insufflation 
technique compared with an incision measuring approximately 3.5–6 cm for the gasless technique.
Robotic surgery is more ergonomically comfortable than conventional surgery owing to the 3-dimensional 
optics and intuitive robotic arm motion6, and robotic surgery is easier to learn than conventional surgery. As 
reported by previous studies, learning curves for RANSM are rapidly declining5,15,17. In this study, the console 
time was investigated to evaluate proficiency of surgical skills in robotic surgery. CUSUM analyses of the console 
time revealed that it was rapidly stabilized at the eighth case. It can be concluded that surgeons can acquire appro-
priate surgical skills within a relatively short time.
RANSM with IBR (n = 12)
Age (years) 46 (29–51)
BMI (kg/m2) 20.8 (18.59–23.93)
Breast weight (g) 225.5 (150–436)
Diagnosis
Benign 2 (16.7)
DCIS 1 (8.3)
IDC 9 (75)
Tumor size (cm) (n = 10)* 2.3 (0.5–4.2)
No. of metastatic lymph nodes (n = 10)*
0 8 (80)
1 2 (20)
Histopathological grade (n = 10)*
1 0 (0)
2 6 (60)
3 4 (40)
Estrogen receptor status (n = 10)*
Negative 0 (0)
Positive 10 (100)
Progesterone receptor status (n = 10)*
Negative 1 (10)
Positive 9 (90)
HER2 status (n = 10)*
Negative 7 (70)
Positive 3 (30)
Ki 67 (n = 10)*
Low (<14%) 5 (50)
High (≥14%) 5 (50)
Adjuvant chemotherapy (n = 10)*
No 6 (60)
Yes 4 (40)
Radiotherapy (n = 10)*
No 8 (80)
Yes 2 (20)
Hormonal therapy (n = 10)*
No 0 (0)
Yes 10 (100)
Targeted therapy (n = 10)*
No 9 (90)
Yes 1 (10)
Table 1. General characteristics of the study population. Values are represented as median (minimum–
maximum) or N (percentage). *2 cases showed a benign presentation. BMI: body mass index, DCIS: ductal 
carcinoma in situ, HER: human epidermal growth factor receptor, IBR: immediate breast reconstruction, IDC: 
invasive ductal carcinoma, RANSM: robot-assisted nipple-sparing mastectomy.
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RANSM with IBR 
(n = 12)
Operated site
Left 5 (41.7)
Right 7 (58.3)
Reconstruction
Tissue expander insertion 9 (75)
Direct-to-implant 3 (25)
Gas insufflation
No 10 (83.3)
Yes 2 (16.7)
SLNB (n = 10)*
No 0 (0)
Yes 10 (100)
ALND (n = 10)*
No 9 (90)
Yes 1 (10)
Length of hospitalization (days) 11 (9–13)
Total operation time (min) 351 (267–480)
Console time (min) 51 (18–143)
Margin status
Negative 10 (83.3)
Positive 2 (16.7)
Complication
None 9 (75)
Skin ischemia 2 (16.7)
Nipple ischemia 1 (8.3)
Table 2. Surgical methods and postoperative outcomes. Values are represented as median (minimum–
maximum) or N (percentage). *2 cases showed a benign presentation. ALND: axillary lymph node dissection, 
IBR: immediate breast reconstruction, RANSM: robot-assisted nipple-sparing mastectomy, SLNB: sentinel 
lymph node biopsy.
Figure 2. The learning curve of the robot-assisted nipple-sparing mastectomy with immediate breast 
reconstruction. (A) The learning curve of the total operation time. (B) The learning curve of the console time. 
CUSUM: cumulative sum.
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Owing to limited data regarding long-term outcomes, RANSM is performed only in highly selected patients, 
primarily patients with early breast cancer, healthy carriers showing BRCA1/2 mutation, and those with benign 
disease. In this study, nearly all patients demonstrated early breast cancer. Toesca et al. enrolled patients with 
early breast cancer and carriers with BRCA1/2 mutations5,7. Sarfati et al. suggested that unaffected carriers with 
BRCA1/2 mutation could be good candidates for RANSM with IBR8,17. Indications outlined in the previous study 
were similar to those in our study. In the current study, 1 patient underwent RANSM with IBR because of bilateral 
interstitial mastitis. A previous study has suggested that NSM with IBR can be used to treat this condition18. We 
reported the first attempt to treat bilateral interstitial mastitis using robotic surgery (Table 3).
No major complications were reported among patients who underwent RANSM with IBR. A previous study 
reported a postoperative complication rate of 10.3%5. Skin blistering, partial necrosis of the skin and nipple, and 
temporary neurapraxia are common postoperative complications of RANSM5,15,17. These complications can be 
managed conservatively as reported by previous studies, which concurs with our results. Toesca et al. reported 
that the conversion rate to open surgery was 6.9% in those who underwent RANSM; however, no patient required 
conversion to open surgery in our study5 (Table 3).
The limitations of this study are as follows: Owing to the small size and retrospective design, the role of a 
selection bias and uncontrolled confounders cannot be completely excluded. Furthermore, long-term survival 
outcomes remain unknown because this is our initial experience of RANSM with IBR. RANSM with IBR was 
performed only in a highly selected group of patients such as those with early breast cancer and benign disease. 
To overcome these limitations, prospective trials are warranted to evaluate the stability and the cosmetic effects of 
the surgery. RANSM with IBR has not been standardized because of the insufficient evidence regarding the safety 
and efficacy of the various methods. Large prospective randomized studies are needed to definitively establish a 
more accurate and stable surgical procedure.
conclusion
RANSM with IBR is a feasible and safe surgical treatment for early breast cancer and benign conditions. Although 
robotic technology is a relatively recent introduction, RANSM with IBR showed a rapid learning curve.
Data availability
The data of the current study are available from the corresponding author on reasonable request.
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